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Abstract
During Herpes simplex virus envelopment, capsids, tegument polypeptides, and membrane proteins assemble at the site of budding and
a cellular lipid bilayer becomes refashioned into a spherical envelope. Though the molecular interactions driving these events are poorly
understood, several lines of evidence suggest that associations between envelope protein cytoplasmic tails and tegument polypeptides may
play important roles. Consistent with this hypothesis, we show here that a fusion of the cytoplasmic tail of gH with Glutathione-S-
Transferase binds to VP16 in a temperature-dependent manner. VP16 prepared by in vitro translation behaves in a similar fashion,
demonstrating that the interaction is not dependent on other viral polypeptides. Mutational analysis of the gH tail has also enabled us to
identify amino acid residues critical for VP16 binding in vitro. A fusion protein in which the gH tail is fused to the carboxy-terminus of
GFP coimmunoprecipitates with VP16 in infected cells, indicating that VP16 can interact with the gH tail in vivo.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
The Herpesvirus particle is composed of a proteinaceous,
icosahedral capsid that is assembled and packaged with the
double-stranded DNA genome in the nucleus of infected
cells. The mature capsid is surrounded by a complex of
proteins known as the tegument and is enveloped within a
lipid bilayer derived from host cell membranes. This enve-
lope also contains a number of virally encoded glycopro-
teins (Roizman and Pellett, 2001). While the site of final
tegument and envelope assembly has been controversial
(Enquist et al., 1998; Mettenleiter, 2002), recent genetic,
biochemical, and ultrastructural data suggest that Herpes
simplex virus type 1 (HSV-1) capsids acquire their final
envelope and tegument layer by budding into the trans-
Golgi network (TGN) or endosomes (Browne et al., 1996a;
Brunetti et al.,1998; Whiteley et al.,1999; Harley et al.,
2001; Skepper et al., 2001; McMillan and Johnson, 2001;
Miranda-Saksena et al., 2002).
In HSV-1, at least 15 different viral polypeptides have
been identified as components of the tegument, and more
than 10 different glycoproteins are associated with the en-
velope (Spear, 1994; Roizman and Knipe, 2001). Many of
the tegument polypeptides serve multiple functions at dif-
ferent steps in the viral replication cycle. For example, the
tegument protein encoded by UL48 is the 65-kDa phospho-
protein VP16, a transcriptional activator of immediate-early
gene products (Roizman and Knipe, 2001), and also a mod-
ulator of the UL41 gene product vhs (Lam et al., 1996),
which degrades cellular and viral mRNA (Everly et al.,
2002). Consistent with its location in the tegument, it has
been shown that VP16 is required for proper viral assembly
and egress (Mossman et al., 2000). Deletion of VP16 in
HSV prevents the accumulation of enveloped cytoplasmic
capsids. Though perinuclear enveloped virions do form,
their envelope morphology appears altered (Mossman et al.,
2000).
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Although it is generally agreed that HSV capsids acquire
their final envelope by budding into a cytoplasmic or-
ganelle, little is known of the molecular details of this
process. It seems reasonable to suppose that budding occurs
as a result of interactions between the viral capsid, tegument
proteins, and the cytoplasmic tails of envelope glycopro-
teins. This would ensure that all of the required components
of the virus would come together to facilitate assembly of
the mature infectious particle. Consistent with this hypoth-
esis, several interactions have been identified between dif-
ferent components of tegument, and between tegument and
glycoproteins. For example, in addition to its association
with the tegument polypeptide vhs (Smibert et al., 1994;
Lam et al., 1996), VP16 also binds the tegument protein
VP22, the product of the UL49 gene (Elliott et al., 1995).
Additionally, the HSV-1 glycoproteins gH, gB, and gD can
be chemically crosslinked to VP16 in purified virions, sug-
gesting that they are, at least, in very close proximity to this
tegument component (Zhu and Courtney, 1994). In pseudo-
rabies virus (PrV), the tegument proteins encoded by UL36
and UL37 have also been shown to associate with each
other (Klupp et al., 2002). These proteins clearly play an
important role in assembly, since deletion of either UL36 or
UL37 in HSV-1 (Desai, 2000; Desai et al., 2001) and UL37
in PrV (Klupp et al., 2001) dramatically inhibit virus mat-
uration. Furthermore, recent data have shown that the tails
of the PrV envelope glycoproteins gE and gM bind to VP22
in a yeast two-hybrid study (Fuchs et al., 2002). Consistent
with this observation, simultaneous deletion of gM and the
gE/gI heterodimer results in reduced amounts of VP22 in
the mature PrV particle, and in the formation of capsid-
bound tegument aggregates in the cytoplasm (Brack et al.,
1999, 2000; Fuchs et al., 2002). These studies also illustrate
the considerable amount of redundancy present in the as-
sembly process, as deletion of either gM or the gE/gI het-
erodimer alone had little effect on VP22 incorporation
(Fuchs et al., 2002). Only simultaneous deletion of all three
glycoproteins, or deletion of gM combined with deletion of
the gE cytoplasmic tail, was sufficient to inhibit particle
morphogenesis (Brack et al., 1999, 2000). Similarly, dele-
tion of gD, gE, and gI in HSV-1 has recently been shown to
cause a major defect in assembly, resulting in accumulation
of unenveloped capsids in the cytoplasm that are embedded
in tegument-like material. This result has been interpreted to
imply that gD, gE, and gI act in a redundant fashion to
anchor the virion envelope onto tegument-coated capsids
(Farnsworth et al., 2003).
Crosslinking of VP16 to the cytoplasmic tails of gB, gH,
and gD (Zhu and Courtney, 1994) provided the first indi-
cation of which tegument/glycoprotein tail interactions may
occur in the HSV-1 particle. The potential association be-
tween VP16 and gH provides a particularly attractive model
system for studying assembly, since gH has a short cyto-
plasmic tail consisting of 14 amino acid residues, making it
easily amenable to mutagenic analysis. However, the fact
that gH and the gH cytoplasmic tail can be deleted with no
apparent effect on HSV assembly (Forrester et al., 1992;
Wilson et al., 1994; Harman et al., 2002) suggests that, as in
PrV, redundant protein–protein interactions might make a
genetic analysis difficult. To circumvent this problem, we
attempted to reconstitute VP16/gH association in a simpli-
fied, biochemically accessible system. To this end, we pre-
pared Glutathione-S-Transferase (GST) fusion proteins that
bear the cytoplasmic tail of gH or mutants thereof at their
carboxy-termini. Following their binding to Glutathione-
Sepharose beads and incubation with HSV-infected cell
extracts, these fusion proteins were tested for their ability to
interact with VP16. Here we report that the cytoplasmic tail
of gH does indeed bind to the tegument protein VP16 in
vitro, consistent with the in vivo studies of Zhu and Court-
ney (1994). Additionally, we have found that the interaction
between the gH tail and VP16 in this experimental system is
independent of the presence of other viral polypeptides.
Furthermore, we have mapped the residues in the gH tail
that are critical for binding VP16 and show that binding is
optimal at physiological temperature. To test the signifi-
cance of these findings for in vivo binding between VP16
and gH, we have transfected cells with constructs express-
ing green fluorescent protein (GFP) fused to wild-type or
mutant versions of the gH cytoplasmic tail, and then in-
fected the cells with HSV-1. By immunoprecipitating the
extracts of these cells with anti-GFP antibodies, we have
shown that VP16 and the gH carboxy-terminus interact with
similar sequence dependence as in vitro.
Results
Generation of a GST-gH tail fusion to test for interaction
with VP16
We used the vector pGEX-KG (Guan and Dixon, 1991)
to prepare in-frame fusions between the coding sequence of
GST and DNA encoding the cytoplasmic tail of gH (Fig.
1A). Escherichia coli were transformed with pGEX-KG or
the gH tail-GST construct, treated with IPTG to induce
expression, and subjected to SDS–PAGE. In Fig. 1B, Coo-
massie blue staining shows that fusion proteins of the cor-
rect size were readily apparent as the most prominent pro-
tein band in the gel. These bands were also reactive with
anti-GST antibodies following immunoblotting (data not
shown).
Binding of the tegument polypeptide VP16 to the gH tail
fusion protein
We previously described methods for the isolation of
HSV-containing organelles and putative assembly interme-
diates from the cytoplasm of HSV-infected cells (Harley et
al., 2001). We reasoned that such organelles would be a
convenient source of VP16 that may be capable of interact-
ing with the HSV gH tail. To test this possibility, we
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prepared a postnuclear supernatant (PNS) from HSV-in-
fected COS cells and solubilized the viral structural proteins
by incubation with NP-40 and NaCl (we have previously
found that many tegument polypeptides are insoluble in the
PNS, perhaps due to their incorporation into assembling
virions—data not shown). This detergent-solubilized ex-
tract was then incubated for 1 h with Glutathione-Sepharose
beads, which were previously bound to equivalent amounts
of GST or the gH tail-GST fusion protein (termed GST-gH).
Material that was bound and unbound to the beads was
resolved by SDS–PAGE and then analyzed by Western blot.
Fig. 2A shows our results for the binding of the tegument
protein VP16 to GST-gH (gH); Western blots of material
bound (b) and unbound (u) to the beads show the relative
amount of VP16 binding to the gH tail under our conditions.
Additionally, bead-bound material from the same experi-
ment was subjected to SDS–PAGE and visualized by Coo-
massie staining to show the relative levels of GST and
GST-gH fusion protein. To optimize our conditions, we
tested binding at several different temperatures. We found
that binding of VP16 to the gH tail was strikingly dependent
on temperature (Fig. 2B). VP16 bound to GST-gH (gH)
only at 37°C and failed to bind at 4°C or room temperature
(RT) after a 1-h incubation.
Fig. 1. Construction and expression of a GST-gH fusion protein. (A) Schematic of the fusion protein expression region of plasmid pGEX-KG. In the lower
bar is indicated the IPTG inducible promoter Ptac, the direction of transcription (gray arrow), and the GST open reading frame (black bar). Following the
polyglycine flexible hinge (GGGGG) is the polylinker region (hatched bar), flanked by the EcoRI and HindIII restriction sites used in this study. DNA
encoding the gH cytoplasmic tail and the amino acid sequence of the tail are shown above the vector backbone. The tail is fused in-frame with GST at the
EcoRI site and terminates with two in-frame stop codons prior to the HindIII site, as indicated. Asterisks indicate additional stop codons provided by the
vector. Sequences required for bacterial growth and antibiotic selection are not shown. (B) Escherichia coli were transformed with the parental vector (GST)
or with the plasmid encoding a fusion between GST and the gH tail (gH) as indicated. Following IPTG induction, 1, 2, or 5 volume equivalents (as indicated)
of total bacterial extract were subjected to 12% SDS–PAGE and proteins were visualized with Coomassie brilliant blue. Positions and sizes (in kDa) of
standard molecular weight markers are indicated at the left of the figure. Arrowhead at right indicates the position of GST and the GST-gH fusion.
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Lack of binding to GST, and restriction of binding to
physiological temperature, was suggestive of a specific in-
teraction between VP16 and the gH tail. However, this
specificity was further examined in two different ways.
First, we reasoned that if binding is specific, it should be
saturable. To test this, constant, equal amounts of GST and
GST-gH were incubated with increasing amounts of in-
fected cell cytosol, and Western blotted for VP16 (Fig. 3A).
Binding of VP16 to GST-gH (gH) saturated between 4 and
10 volume equivalents of cytosol, indicating that there are
limited numbers of binding sites for VP16 within GST-gH,
and therefore, VP16 binding to GST-gH is specific. Note
that as increasing amounts of cytosol are added, levels of
VP16 binding to GST-gH decrease. We speculate that this
reproducible result may be caused by an increase in abun-
dance of proteins, such as other tegument components, that
may compete with VP16 for association with the gH tail
when present at sufficient concentration. In contrast, bind-
ing of VP16 to GST continued to increase as increasing
amounts of cytosol were added, indicating that the level of
binding of VP16 to GST alone was not only low, but also
nonsaturable, and presumably, nonspecific. As a second test
for specificity, Fig. 3B shows the binding of GST and
GST-gH to various cellular and viral polypeptides. The
cellular protein Actin, the capsid scaffold proteins ICP35
and Pra (which share a common carboxy-terminal portion
recognized by the antibody used), and the tegument protein
VP22 all fail to bind to GST-gH under our conditions,
indicating that gH does not nonspecifically bind abundant
viral or cellular proteins.
Alanine scanning mutagenesis of the gH cytoplasmic tail
To identify residues in the gH tail that are important for
VP16 binding, we performed alanine scanning mutagenesis,
mutating either single residues or groups of residues in the
gH carboxy-terminus. The mutants were generated in the
same way as the wild-type gH tail-GST fusion (Materials
and methods), and the resulting GST fusions named based
on the residue(s) mutated to alanine. These mutants, as well
as GST-gH and GST, were expressed and subjected to
binding assays, and the relative levels of VP16 binding to
the mutants were detected by Western blot. In addition,
following SDS–PAGE of binding reactions, gels were Coo-
Fig. 3. Specificity of interaction between VP16 and the gH tail. (A)
Saturation of VP16 binding to GST-gH. GST-gH- or GST-coated beads
were incubated with increasing amounts of infected cell cytosol, and then
Western blotted and probed for VP16. Panels show material bound (b) and
unbound (u) to GST-gH (gH) or GST. Volume equivalents of cytosol
added are indicated above the respective lanes. (B) Control cellular and
viral proteins do not bind to the gH tail. Duplicate bindings of GST-gH
(gH) and GST (as indicated above respective lanes) were subjected to
Western blot and probed with antibodies specific to actin, ICP35 and Pra,
or VP22 (as indicated to the left of the figure). Lanes representing bound
(b) and unbound (u) material are indicated at the top of the figure. Position
and sizes (in kDa) of molecular weight markers are indicated at the right.
Fig. 2. Binding of the gH cytoplasmic tail to VP16. GST or GST-gH
fusions were induced; bacterial extracts were prepared and equivalent
amounts of each protein were bound to Glutathione–Sepharose beads.
These beads were then incubated with cytosol prepared from HSV-1-
infected COS cells at 37°C or as otherwise indicated. Bound or unbound
polypeptides were resolved by 8% SDS–PAGE, transferred to a nitrocel-
lulose filter, and probed with anti-VP16 antibody, as indicated. (A) Top
two panels show anti-VP16 Western blots of duplicate samples bound (b)
and unbound (u) to GST-gH (gH) and GST (as indicated above the figure).
In the bottom panel, binding reactions were resolved by a 12% SDS–PAGE
and stained with Coomassie brilliant blue to show the levels of GST fusion
proteins used in this experiment. (B) Temperature dependence of VP16
binding. Infected cell cytosol was incubated with GST or GST-gH-coated
Sepharose beads for 1 h at 4°C, 37°C, or room temperature (RT), as
indicated at the top of the figure. Bound material was then Western blotted
for VP16.
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massie-stained to show the relative levels of each of the
fusion proteins present in the reaction. Fig. 4A demonstrates
that mutation of the valine-leucine-arginine residues at the
amino-terminal end of the tail (VLR), as well as mutation of
the pair of centrally located phenylalanines (FF) and pair of
arginines close to the carboxy-terminus (RR), abolish bind-
ing of VP16 to the gH tail, indicating that some or all of
these residues play a critical role in VP16 binding. Mutating
a carboxy-proximal tryptophan residue (W) to alanine con-
sistently reduced binding to VP16, suggesting that it plays
an important, albeit not crucial, role in VP16 binding under
our conditions. Unexpectedly, mutation of the glutamic acid
residue (E) at the C-terminal end of the tail, and the proline
residue (P) at the center of the tail, actually enhanced bind-
ing of VP16 relative to the wild-type sequence. This result
was especially apparent in the case of the P mutant. Each of
the threonine-serine-valine residues amino-terminal to the
center of the tail (TSV) appeared unimportant for binding,
although the valine residue has been previously shown to
play a role in modulating syncytium formation during in-
fection (Wilson et al., 1994).
In light of the data above, we proceeded to make finer
mutations in the gH tail by altering potentially important
residues individually to alanine. Fig. 4B shows Western
blots and Coomassie-stained gels of binding experiments
using these new mutants. From these experiments we de-
termined that the leucine residue (L) near the N-terminus of
the tail, each of the central phenylalanine residues (F1 and
F2), and each of the carboxy-proximal arginine residues (R2
and R3) are required for VP16 binding. The amino-proximal
lysine (K), valine (V), and arginine (R1) seem to play no
role in VP16 binding.
Since the gH cytoplasmic tail is short, we were interested
to know if the peptide inserts into a shallow groove on its
binding partner. This is not without precedent—the sorting
motif KDEL, present in the carboxy-termini of lumenal ER
proteins, inserts into a short channel in its receptor, and
addition of a single residue to the end of the motif abolishes
binding (Munro and Pelham, 1987; Wilson et al., 1993).
Therefore, we created a mutant with an extra alanine residue
at the C-terminus of the gH tail and then tested its binding
to VP16. As shown in Fig. 4C, the extended tail mutant
(A) bound to VP16 in a manner similar to wild-type.
Physiological temperature-dependent binding of VP16 to
gH is controlled by the centrally located proline residue
We showed in Fig. 2B that VP16 binds to gH at 37°C
after a 1-h incubation, but not at 4°C or at RT. Since
mutating the proline residue in the gH tail to alanine dra-
Fig. 4. Alanine scanning mutagenesis of the gH-tail. Single residues or groups of residues were mutated to alanine, and the resulting GST-gH mutants were
named according to the residues changed. The mutants were subjected to binding experiments, in duplicate, and then Western blotted for VP16 or Coomassie
stained for fusion protein levels, as indicated at the left of the panels. Binding of wild-type GST-gH (gH) and GST alone are shown as positive and negative
controls. (A) Binding of VP16 to preliminary mutants of the gH tail, in which every residue in the gH tail was mutated alone or in groups to alanine. (B)
Individual residues of the gH tail were mutated to alanine and fused to GST, and then subjected to a binding assay. (C) An extended gH tail mutant (A)
was constructed in which an extra alanine residue was added at the carboxy-terminus of the wild-type sequence. Wild-type gH tail sequence is indicated at
the top of the figure.
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matically increased binding of VP16 compared to wild-type
under physiological conditions (Fig. 4A), we were inter-
ested to determine whether loss of the proline residue would
alleviate the temperature restriction and enable binding of
VP16 at lower temperatures. We therefore performed VP16
binding reactions with GST, GST-gH, and the P mutant at
37°C, 4°C, or RT for either 1 h or overnight (16–18 h). In
Fig. 5, we show Western blots of bound (b) and unbound (u)
material from these experiments. Fig. 5A demonstrates that
mutation of the central proline residue to alanine does result
in the ability of this tail to bind VP16 at 4°C. However,
binding must be for an extended period of time, 16–18 h.
The wild-type tail continues to fail to interact with VP16 at
4°C even after this extended incubation. Failure of VP16 to
associate with the wild-type gH tail even after prolonged
incubation at 4°C is not due to denaturation or other means
of inactivation of VP16, since when cytosol that had been
incubated overnight at 4°C with the gH tail was warmed to
37°C and reincubated with fresh GST-gH coated beads, the
VP16 in the extract was able to bind (indicated by “r” in Fig.
5A).
Fig. 5B shows binding of GST, GST-gH, and the proline
mutant at room temperature compared to 37°C. In contrast
to our results at 4°C, VP16 was capable of binding to the
wild-type gH tail after an overnight incubation. Further-
more, the proline mutant once again demonstrated increased
VP16 binding, as it only required 1 h to bind a significant
level of VP16, whereas wild-type gH was incapable of
binding detectable levels of VP16 in 1 h at room tempera-
ture (Fig. 2B).
VP16 binds to the gH tail independently of other viral
polypeptides
Since VP16 is part of the complex network of proteins in
the HSV tegument, we were interested to determine whether
VP16 binding to the gH cytoplasmic tail was mediated by
other viral polypeptides. To test this, we used a rabbit
reticulocyte lysate system to express 35S-labeled VP16
polypeptide in vitro, in the absence of any other viral fac-
tors. We then incubated the in vitro translated (IVT) VP16
with Glutathione-Sepharose beads, which had been pre-
coated with GST, GST-gH, or various mutants. Fig. 6A
shows binding of IVT VP16 under standard conditions
(incubation at 37°C for 1 h) with GST, GST-gH, as well as
two mutants, P, which enhances binding of cytosolic VP16
Fig. 5. Temperature dependence of VP16 binding to wt gH and the proline-to-alanine mutant. GST or the fusion proteins were incubated in duplicate with
infected cell cytosol at either 4°C, RT, or 37°C, as indicated at the top of each figure. Binding took place for 1 h (1) or overnight (o/n), as indicated above
each lane. Panels show Western blots for VP16 of either material bound (b) to the fusion proteins, or unbound (u). (A) Binding of VP16 to gH and P mutant
compared at 4 and 37°C. Unbound material from one of the duplicate gH samples was then rebound (r) to fresh GST-gH-coated Sepharose beads for 1 h
at 37°C. (B) Binding of VP16 to gH and P mutant compared at room temperature and 37°C.
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compared to wild-type (Fig. 4A); and R2, which diminishes
binding of cytosol-derived VP16 (Fig. 4B). We found that
IVT VP16 bound to GST-gH but not to GST alone and that
it bound to the two mutants in a similar fashion as cytosolic
VP16 (Fig. 6A). To further compare the binding character-
istics of IVT and cytosolic VP16, we tested the temperature
dependence of binding. In Fig. 6B, autoradiographs of IVT
VP16 binding to GST-gH, GST, and the P mutant show
results similar to those obtained using cytosol-derived
VP16: IVT VP16 does not bind GST-gH at 4°C after an
overnight incubation, whereas the P mutant binds. Further-
more, IVT VP16 binds GST-gH after an overnight incuba-
tion at RT, whereas it binds to the P mutant after both an
overnight and a 1-h incubation. Since there was no apparent
difference between cytosolic and IVT VP16 with respect to
VP16/gH tail interaction, we conclude that VP16 binds to
the gH cytoplasmic tail independently of other viral
polypeptides.
VP16 binds to the gH cytoplasmic tail in vivo
All of the experiments performed above utilized in vitro
techniques to establish the binding of VP16 to gH. To
ascertain that a similar interaction occurs in vivo, immuno-
precipitation experiments were carried out in infected cells.
To do this, we fused the gH tail to the carboxy-terminus of
GFP. Details of the construction of this plasmid, as well as
plasmids encoding GFP fused to gH tail mutants, are de-
scribed under Materials and methods.
COS cells were mock transfected or transfected with
GFP alone or GFP-gH fusions. Approximately 30 h post-
transfection, the cells were infected with HSV. Fifteen
hours postinfection the cells were collected and extracts
were prepared (see Materials and methods). The cell lysates
were then precleared with Protein A agarose beads at the
temperature later used for immunoprecipitation to minimize
subsequent nonspecific binding. Precleared lysates were
then incubated for 30 min at 30 or 37°C with Protein A
agarose beads which had been precoated with anti-GFP
polyclonal antibodies. After washing the beads, immuno-
precipitated material, as well as material that did not bind to
the beads, was subjected to SDS–PAGE and Western blot-
ted with anti-GFP or anti-VP16 antibodies to assess the
efficiencies of GFP immunoprecipitation and to test whether
VP16 had been coimmunoprecipitated. Fig. 7A shows that
VP16 was coimmunoprecipitated with the GFP-gH fusion,
but not with GFP alone or with mock-transfected cells.
Additionally, VP16 did not coimmunoprecipitate with
Fig. 6. Binding of in vitro translated (IVT) VP16 to the gH tail. 35S-labeled VP16 was expressed by in vitro translation and incubated with GST-gH, GST,
or various GST-gH-derived mutants as indicated in the figure. Shown are autoradiographs of material bound (b) and unbound (u) to the GST fusions, as
indicated at the left of the figure. (A) Binding of IVT VP16 to GST-gH, GST, as well as the P and R2 mutants, as indicated. (B) IVT VP16 was incubated
with gH, GST, and the P mutant at 37°C, 4°C, or RT, as in Fig. 5.
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GFP-gH at 30°C (Fig. 7A) or at 4°C (data not shown),
consistent with our in vitro binding experiments. In the
lower panel, blotting with anti-GFP antibodies shows that
similar amounts of GFP and GFP-gH were present in the
immunoprecipitate.
To test the correspondence between in vivo and in vitro
binding, we assessed the in vivo binding characteristics of
some of the mutants generated in our in vitro investigation.
To this end, we prepared GFP fusions to two gH tail mu-
tants, the proline-to-alanine (P) mutant, which binds with
greater efficiency to VP16 (Fig. 4A), and the double argi-
nine-to-alanine (RR) mutant, which does not bind VP16 in
vitro (Fig. 4A). Fig. 7B shows the results of immunopre-
cipitation studies using these mutants. Consistent with our
in vitro studies, the P mutant showed enhanced binding to
VP16 compared to wild-type GFP-gH, even though it was
present at reduced levels in the immunoprecipitate (see
Western blot using anti-GFP antibody in bottom panel).
Furthermore, the RR mutant showed diminished binding to
VP16. Note that in Figs. 7A and B, the amount of unbound
material loaded on the gels was 20- and 10-fold less (re-
spectively) than the amount of immunoprecipitated mate-
rial, and therefore only a very small proportion of total
VP16 was observed to coimmunoprecipitate with the
GFP-gH fusion. This may reflect the fact that, during HSV
infection, only a small fraction of the structural proteins
synthesized are assembled into virions. Additionally, the
GFP proteins are only expressed in transfected cells, which
are in a minority, whereas all of the cells are infected with
HSV, and thus express VP16.
Discussion
Zhu and Courtney reported that gH could be crosslinked
to VP16 in purified virions (Zhu and Courtney, 1994),
indicating a potential interaction between the two proteins.
We have examined this possibility by preparing a gH tail-
GST fusion protein and incubating it with HSV-infected cell
cytosol as a source of VP16. Under these in vitro conditions,
we have shown that the tegument protein VP16 does indeed
bind to the cytoplasmic domain of gH. Under our condi-
tions, the binding of VP16 to the gH C-terminus is satura-
ble, indicating that there are a limited number of VP16
binding sites on the fusion protein. The gH tail does not
interact with HSV structural proteins VP22 and ICP35, nor
with the cellular protein, actin. Additionally, we have found
that VP16 binds to the gH cytoplasmic tail in a strikingly
temperature-dependent manner; binding within 1 h occurs
only at 37°C, but not at 4°C or room temperature. Taken
together, we believe that these data suggest that the in vitro
interaction of VP16 with the gH cytoplasmic tail is specific.
By performing alanine scanning mutagenesis of the gH
tail, we have identified five residues that are critical for
VP16 binding. The five residues are interspersed in the tail,
with a leucine residue (L) at the N-terminal portion, two
paired phenylalanine residues (FF) in the center, and two
paired arginine residues (RR) toward the carboxy end. Un-
expectedly, we also found that mutation of the C-terminal
glutamic acid residue (E), and the central proline residue
(P), actually increased the amount of VP16 bound; en-
hanced binding of VP16 to the proline mutant was partic-
ularly apparent.
There is no extensive conservation of the sequence of the
gH cytoplasmic tail among different species of herpesvi-
ruses. However, inspection of predicted gH tail sequences
deposited in the Swissprot, PIR, and translated GenBank
databases reveals that two residues, which appear in this
study to play an important role in VP16 interaction, are
somewhat conserved among the alphaherpesviruses. The
leucine residue at the third position C-terminal from the
transmembrane domain is conserved among bovine herpes-
Fig. 7. Coimmunoprecipitation of GFP-gH and VP16. COS cells were
mock-transfected (MT) or transfected with plasmids expressing GFP alone,
or GFP fused to the gH tail (gH) or mutants thereof as indicated, and then
infected with HSV-1. Fifteen hours postinfection, the cells were incubated
with lysis buffer (see Materials and methods) for 30 min on ice. After
pelleting the debris, cell extracts were incubated with Protein A agarose
beads precoated with rabbit anti-GFP antibody for 30 min at the indicated
temperatures and washed in lysis buffer. Material that immunoprecipitated
with anti-GFP antibody (IP), as well as material that was in the unbound
fraction (u), was subjected to SDS–PAGE and Western blotted using
mouse anti-VP16 or anti-GFP antibodies, as indicated at the left of the
panels. Note that 1/20th of the total unbound material was run on the gel.
(A) Coimmunoprecipitation of VP16 at 37 or 30°C by wild-type gH tail.
(B) Coimmunoprecipitation of VP16 by gH tail mutants at 37°C. P mutant
is used as an example of a mutant that enhances binding to VP16, and RR
represents a mutant that abolishes binding to VP16 in vitro (see Fig. 4A).
Note that 1/10th of the total unbound material was loaded on the gel.
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virus (BHV) type 1, BHV-2, BHV-5, equine herpesvirus
(EHV) type 1, EHV-4, PrV, feline herpesvirus (FeHV) type
1, and canine herpesvirus (CaHV) type 1, although it is not
conserved in HSV-2 (where it is instead a valine), nor in
varicella zoster virus (VZV). The proline eight residues
C-terminal from the transmembrane domain, in the center of
the tail, is also conserved in several different species of
herpesviruses, including HSV-2, BHV-1, BHV-2, and
BHV-5, CeHV-1, and FeHV-1; in VZV the proline residue
is predicted to be one residue further from the inner surface
of the envelope.
Binding of VP16 to gH was strikingly affected by tem-
perature. This could indicate some temperature-dependent
biochemical modification of VP16, or of other polypeptides
in the extract, which may be a prerequisite for interaction
with the gH tail. However, preincubation of infected cell
extracts at 37°C did not permit subsequent binding of VP16
to GST-gH at 4°C (data not shown), suggesting that if such
modifications occur, they are reversed at 4°C or require the
simultaneous presence of the gH tail. Alternatively, the
temperature dependence of binding of VP16 to gH, together
with the enhanced binding of VP16 to the proline mutant
and the distribution of residues involved in VP16 associa-
tion, suggested to us that VP16/gH interactions might be
dependent on the structural conformation of the gH tail. In
this model, the conformation of gH at 37°C is compatible
with VP16 binding, but at reduced temperatures the tail
undergoes conformational changes which preclude its asso-
ciation with VP16. Since the proline-to-alanine mutant is
capable of binding VP16 at room temperature after 1 h, and
at 4°C after an overnight incubation, loss of the proline may
favor the tail adopting a binding conformation even below
37°C. We are investigating the role of the structural con-
formation of the gH tail in VP16 association using 1D and
2D NMR studies at various temperatures.
Since VP16 is part of the complex tegument structure,
and a number of tegument polypeptides are known to inter-
act with VP16, we were interested to test whether VP16
bound to the gH tail directly or via another viral protein. We
therefore translated VP16 in an in vitro system and studied
its binding to gH. We found that in vitro translated VP16
does bind specifically to GST-gH and that the temperature
dependence of binding and dependence on the presence of
particular residues in the gH tail are similar to that of
infected cell VP16. This leads us to conclude that, under our
conditions, binding of VP16 to the gH tail is independent of
other viral polypeptides.
Since the experiments discussed above were all per-
formed under in vitro conditions, we wanted to confirm that
this interaction also occurs in vivo. To test this, we con-
ducted coimmunoprecipitation experiments using the gH
tail fused to GFP. In this fashion we were able to demon-
strate that VP16 can interact specifically with the gH tail in
an infected cell. Additionally, by performing these experi-
ments using GFP fused to mutated gH tails, we have shown
that at least two of the mutants behave with similar charac-
teristics in vivo as in vitro. We also found that the in vivo
association between VP16 and the gH carboxy-terminus is
dependent on temperature, binding at 37°C, but not at lower
temperatures, consistent with our in vitro data.
The association between VP16 and gH may be one of
many interactions between glycoprotein tails and tegument
proteins that facilitate the budding of capsids into organelles
and the incorporation of tegument and/or glycoproteins into
enveloping virions. When VP16 is deleted, cytoplasmic
capsids fail to envelope, and perinuclear virions accumulate
that appear to have a much smoother envelope than wild-
type particles (Mossman et al., 2000). This may imply that
VP16 could play a key role in sequestering membrane
proteins to the site of envelope formation. However, a
recent study appears to indicate that the C-terminal domain
of gH is dispensable for gH incorporation into mature,
secreted virions (Harman et al., 2002), which would suggest
that gH tail/tegument interactions are not essential for in-
corporation of gH into mature particles. This is consistent
with the observation that deletion of the nine terminal amino
acids of gH does not significantly reduce PFU yield, al-
though there are effects upon syncytium formation and the
rate of entry of virions during an infection (Wilson et al.,
1994; Browne et al., 1996b). It is possible that there are
additional redundant glycoprotein–glycoprotein interac-
tions in the envelope that facilitate incorporation of gH. In
this regard it is interesting to note that even though the tails
of PrV gE and gM interact with VP22, these glycoproteins
nevertheless can become virion associated even when VP22
is absent (Fuchs et al., 2002). Similarly, it would appear that
VP16 is not dependent upon the tail of gH to ensure its own
incorporation into virions, since the retargeting of gH to
locations not utilized for HSV envelopment apparently does
not affect VP16 incorporation (Browne et al., 1996a). Pre-
sumably, VP16 interacts redundantly with other tegument
proteins (Smibert et al., 1994; Elliott et al., 1995) or glyco-
proteins such as gB and gD (Zhu and Courtney, 1994) to
mediate its incorporation into the particle in the absence of
gH. It seems that, as in PrV, deletion of several glycoprotein
tails and/or tegument proteins will be required to affect




COS7 cells were grown in Dulbecco’s modified Eagle’s
medium supplemented with 1% penicillin-streptomycin and
10% fetal calf serum (Gibco Laboratories). HSV strain
SC16 was prepared as previously described (Church and
Wilson, 1997).
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Antibodies
The anti-VP16 14-5 monoclonal antibody was obtained
from Santa Cruz Biotechnology. The polyclonal, rabbit an-
tiserum raised against the HSV tegument protein VP22 was
kindly provided by Dr. John Blaho. Anti-actin rabbit anti-
serum was obtained from Sigma (A-2066). The rabbit anti-
ICP35 antibody MCA406 was purchased from Serotech.
Monoclonal anti-GFP mouse antibody was acquired from
Clontech (Catalogue no. 8362-1). Polyclonal anti-GFP rab-
bit antibody (ab-290) was purchased from Novus Biologi-
cal.
Construction of gH tail fusion plasmids
The predicted cytoplasmic tail of HSV glycoprotein gH
was fused to the carboxy-terminus of GST using the GST
vector pGEX-KG (Guan and Dixon, 1991). For the wild-
type tail of gH, the complementary oligonucleotides
5AATTCTAAAGGTTCTCCGGACAAGTGTCCCGTTT-
TTTTGGAGACGCGAATGATGAAC TAGTTA3 and 5
AGCTTAACTAGTTCATCATTCGCGTCTCCAAAAAA-
ACGGGACACTTGTCCGGAGAACCTTTAG3 were syn-
thesized and annealed. This generates a dsDNA fragment
with EcoRI and HindIII ends, and which encodes the gH
cytoplasmic tail followed by two stop codons. Ligation of
this fragment with HindIII/EcoRI-digested pGEX-KG DNA
results in an in-frame fusion of the GST and gH tail coding
regions at the EcoRI site. Mutants of the gH cytoplasmic tail
were generated in a similar fashion, with appropriate codons
or groups of codons mutated to encode alanine. Each mutant
also encoded its own unique restriction site between the
second stop codon and the HindIII site, to facilitate identi-
fication by restriction analysis. In many of the mutant oli-
gonucleotides, the sequence encoding the two phenylala-
nines at positions 9 and 10 of the tail was changed from
5TTTTTT3 to 5TTATTT3 to facilitate sequencing. Ad-
ditionally, the mutant sequences differ from the wild-type
oligonucleotides in that they lack a T on the 5-3 primer
(second base from the 3 end) and an A on the 3-5 primer
(seventh base from the 5 end), immediately adjacent to the
HindIII site.
A series of plasmids was constructed expressing the gH
cytoplasmic tail or mutants thereof fused to the carboxy-
terminus of GFP, using a similar method to the above. To





were annealed and ligated to pEGFP-C3 vector (BD Bio-
sciences Clontech) that was previously digested with EcoRI
and BamHI. This generates a plasmid encoding a carboxy-
terminal fusion of the gH tail to GFP. To construct GFP
fusions carrying mutations in the proline and paired arginine
residues, oligonucleotides were synthesized in which the
appropriate codon(s) were changed to those of alanine.
Expression of GST fusion proteins and binding of fusions
to Glutathione-Sepharose beads
All bacterial growth was at 37°C. Appropriate plasmids
were transformed into the E. coli GST fusion protein ex-
pression strain BL21 (Stratagene) and overnight stationary
phase cultures were prepared. These were used to inoculate
fresh medium to an OD600 of 0.2, and the cultures were
grown with vigorous shaking to an OD600 of 0.9. At this
point, fusion protein expression was induced by adding
isopropyl--D-thiogalactopyranoside (IPTG) to a concentra-
tion of 1 mM, and cells were grown for a further 3 h. The
bacteria were then centrifuged at 8000 rpm for 8 min at 4°C
in a GS-3 rotor; the media were removed, and pellets were
frozen at 20°C overnight. The pellets were then thawed,
resuspended in lysis buffer [PBS, 0.05% Tween 20, 50 mM
EDTA, 1 mM PMSF, 5 g/ml leupeptin, 5 g/ml antipain,
1 mg/ml lysozyme], and sonicated using a probe sonicator.
Debris was pelleted at 10,000 rpm for 10 min at 4°C in a
SS-34 rotor, and the resulting supernatant was incubated
with Glutathione-Sepharose beads (Pharmacia), which had
been previously washed twice in PBS. Following overnight
incubation at 4°C, the beads were washed twice with Buffer
1 [50 mM Tris–HCl pH 7.6, 150 mM NaCl, 0.5% Triton
X-100], twice with Buffer 2 [50 mM Tris–HCl pH 7.6, 1.3
M NaCl, 0.5% Triton X-100], and then twice again with
Buffer 1. The resulting beads, bearing specifically bound
GST or GST fusion proteins, were then incubated with
HSV-infected cell extracts, prepared as described below.
Preparation of HSV-1 infected cell extracts and binding
assays
Confluent monolayers of COS-7 cells were infected with
HSV-1 strain SC16 at a multiplicity of 3 and incubated for
16–18 h at 37°C, and a PNS was prepared as previously
described (Harley et al., 2001).
To test for the binding of tegument polypeptides to GST
fusion proteins, PNS was adjusted to 150 mM NaCl, 0.5%
NP-40, 5 g/ml leupeptin, 5 g/ml antipain, 1 mM PMSF,
25 mM Tris–HCl pH 7.6, 100 mM sucrose, 1 mM MgCl2,
and then incubated for 1 h on ice to ensure organelle
solubilization and release of organelle-associated tegument
polypeptides. The mixture was then centrifuged at 53,000
rpm for 1 h in a TLA 100.3 rotor, and the resulting super-
natant was incubated at various temperatures and times with
Sepharose-bound GST fusion proteins. At the end of the
incubation period, the beads were recovered, washed five
times in Buffer 1 (see above), and bead-bound and unbound
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material were examined following SDS– PAGE and West-
ern blotting, as previously described (Harley et al., 2001).
Production of radiolabeled in vitro translated VP16
A plasmid encoding the VP16 open reading frame under
the control of the T7 promoter was transcribed using the
TNT Rabbit Reticulocyte Lysate in vitro translation system
(Promega), as per the manufacturer’s protocol. Redivue
35S-labeled methionine (Amersham Pharmacia) was added
to the in vitro translation reaction to generate labeled VP16.
The IVT VP16 was then mixed with PBS and 5 g/ml
leupeptin, 5 g/ml antipain and incubated at various tem-
peratures and times with GST fusion protein-coated Gluta-
thione-Sepharose beads, as described above. Materials that
were bound and unbound to the beads were then subjected
to SDS–PAGE, and the gel was treated in 30% MeOH, 10%
AcOH for 30 min, Enhance (NEN Life Sciences Product,
Inc.) for 1 h, and 1% glycerol for 30 min, and then dried
using a Bio-Rad Gel Drier. The dried gel was then exposed
to film at 70°C, and the autoradiograph was developed.
Coimmunoprecipitation of GFP-gH and VP16
COS cells were mock-transfected or transfected with
plasmids expressing GFP alone, or GFP fused to the gH tail.
Approximately 30 h posttransfection, the cells were infected
with HSV-1 (strain SC16) at an m.o.i. of 10. After 15 h, the
cells were washed with PBS and incubated with lysis buffer
[20 mM Tris–Cl pH 7.5, 100 mM NaCl, 0.5% NP-40, 0.5
mM EDTA, 0.5 mM PMSF, 5 g/ml leupeptin, 5 g/ml
antipain, 200 g/ml BSA] for 30 min on ice. The extracts
were then pelleted to remove debris, and the resulting cell
lysates were precleared by incubating for 20 min at the
immunoprecipitating temperatures (37 or 30°C) with Pro-
tein A agarose beads (Sigma) that had been prewashed
twice in lysis buffer. The supernatants were then mixed with
fresh Protein A agarose beads that had been preincubated at
4°C for 1 h with 10 g of polyclonal anti-GFP antibody.
Incubation was then performed for 30 min at indicated
temperatures. The agarose beads were then washed five
times in lysis buffer; then bead-bound and unbound material
were subjected to SDS–PAGE and Western blotted using
mouse anti-VP16 or anti-GFP monoclonal antibodies.
Acknowledgments
This work was supported by National Institutes of Health
Grant AI38265 (to D.W.W.) and by NIH training Grant T32
GM07491 (to S.T.G.). Core support was provided by NIH
Cancer Center Grant P30-CA13330. We thank Lily Huang
for technical assistance, and Isabella Chi and Mark Girvin
for helpful discussions.
References
Brack, A.R., Dijkstra, J.M., Granzow, H., Klupp, B.G., Mettenleiter, T.C.,
1999. Inhibition of virion maturation by simultaneous deletion of gly-
coproteins E, I, and M of pseudorabies virus. J. Virol. 73, 5364–5372.
Brack, A.R., Klupp, B.G., Granzow, H., Tirabassi, R., Enquist, L.W.,
Mettenleiter, T.C., 2000. Role of the cytoplasmic tail of pseudorabies
virus glycoprotein E in virion formation. J. Virol. 74, 4004–4016.
Browne, H., Bell, S., Minson, T., Wilson, D.W., 1996a. An endoplasmic
reticulum-retained herpes simplex virus glycoprotein H is absent from
secreted virions: evidence for reenvelopment during egress. J. Virol.
70, 4311–4316.
Browne, H.M., Bruun, B.C., Minson, A.C., 1996b. Characterization of
herpes simplex virus type 1 recombinants with mutations in the cyto-
plasmic tail of glycoprotein H. J. Gen. Virol. 77, 2569–2573.
Brunetti, C.R., Dingwell, K.S., Wale, C., Graham, F.L., Johnson, D.C.,
1998. Herpes simplex virus gD and virions accumulate in endosomes
by Mannose 6-Phosphate-dependent and -independent mechanisms.
J. Virol. 72, 3330–3339.
Church, G.A., Wilson, D.W., 1997. Study of herpes simplex virus matu-
ration during a synchronous wave of assembly. J. Virol. 71, 3603–
3612.
Desai, P., 2000. A null mutation in the UL36 gene of herpes simplex virus
type 1 results in accumulation of unenveloped DNA-filled capsids in
the cytoplasm of infected cells. J. Virol. 74, 11608–11618.
Desai, P., Sexton, G., McCaffrey, J., Person, S., 2001. A null mutation in
the gene encoding the UL37 polypeptide of herpes simplex virus type
1 abrogates virus maturation. J. Virol. 75, 10259–10271.
Elliott, G., Mouzakitis, G., O’Hare, P., 1995. VP16 interacts via its acti-
vation domain with VP22, a tegument protein of herpes simplex virus,
and is relocated to a novel macromolecular assembly in coexpressing
cells. J. Virol. 69, 7932–7941.
Enquist, L.W., Husak, P.J., Banfield, B.W., Smith, G.A., 1998. Infection
and spread of alphaherpesviruses in the nervous system. Adv. Virus
Res. 51, 237–347.
Everly Jr., D.N., Feng, P., Mian, I.S., Read, G.S., 2002. mRNA degradation
by the virion host shutoff (vhs) protein of herpes simplex virus: genetic
and biochemical evidence that vhs is a nuclease. J. Virol. 76, 8560–
8571.
Farnsworth, A., Goldsmith, K., Johnson, D.C., 2003. Herpes simplex virus
glycoproteins gD and gE/gI serve essential but redundant functions
during acquisition of the virion envelope in the cytoplasm. J. Virol. 77,
8481–8494.
Forrester, A., Farrell, H., Wilkinson, G., Kaye, J., Davis-Poynter, N.,
Minson, A.C., 1992. Construction and properties of a mutant of herpes
simplex virus type 1 with glycoprotein H coding sequences deleted.
J. Virol. 66, 341–348.
Fuchs, W., Klupp, B.G., Granzow, H., Hengartner, C., Brack, A., Mundt,
A., Enquist, L.W., Mettenleiter, T.C., 2002. Physical interaction be-
tween envelope glycoproteins E and M of pseudorabies and the major
tegument protein UL49. J. Virol. 76, 8208–8217.
Guan, K.L., Dixon, J.E., 1991. Eukaryotic proteins expressed in Esche-
richia coli: an improved thrombin cleavage and purification procedure
of fusion proteins with glutathione S-transferase. Anal. Biochem 192,
262–267.
Harley, C.A., Dasgupta, A., Wilson, D.W., 2001. Characterization of
herpes simplex virus-containing organelles by subcellular fraction-
ation: a role for organelle acidification in assembly of infectious par-
ticles. J. Virol. 75, 1236–1251.
Harman, A., Browne, H., Minson, A., 2002. The transmembrane domain
and cytoplasmic tail of Herpes simplex virus type 1 glycoprotein H
play a role in membrane fusion. J. Virol. 76, 10708–10716.
11S.T. Gross et al. / Virology 317 (2003) 1–12
Klupp, B.G., Fuchs, W., Granzow, H., Nixdorf, R., Mettenleiter, T.C.,
2002. Pseudorabies virus UL36 tegument protein physically interacts
with the UL37 protein. J. Virol. 76, 3065–3071.
Klupp, B.G., Granzow, H., Mundt, E., Mettenleiter, T.C., 2001. Pseudo-
rabies virus UL37 gene product is involved in secondary envelopment.
J. Virol. 75, 8927–8936.
Lam, Q., Smibert, C.A., Koop, K.E., Lavery, C., Capone, J.P., Weinhei-
mer, S.P., Smiley, J.R., 1996. Herpes simplex virus VP16 rescues viral
mRNA from destruction by the virion host shutoff function. EMBO J.
15, 2575–2581.
McMillan, T., Johnson, D.C., 2001. Cytoplasmic domains of herpes sim-
plex virus gE cause accumulation in the trans-Golgi network, a site of
virus envelopment and sorting of virions to cell junctions. J. Virol. 75,
1928–1940.
Mettenleiter, T.C., 2002. Herpesvirus assembly and egress. J. Virol. 76,
1537–1547.
Miranda-Saksena, M., Boadle, R.A., Armati, P., Cunningham, A.L., 2002.
In rat dorsal root ganglion neurons, herpes simplex virus type 1 tegu-
ment forms in the cytoplasm of the cell body. J. Virol. 76, 9934–9951.
Mossman, K., Sherburne, R., Lavery, C., Duncan, J., Smiley, J., 2000.
Evidence that herpes simplex virus VP16 is required for viral egress
downstream of the initial envelopment event. J. Virol. 74, 6287–6299.
Munro, S., Pelham, H.R., 1987. A C-terminal signal prevents secretion of
luminal ER proteins. Cell 48, 899–907.
Roizman, B., Knipe, D.M., 2001. Field’s Virology, in: Knipe, D.M.,
Howley, P.M. (Eds.), fourth ed., Lippincott Williams & Wilkins, Phil-
adelphia, pp. 2399–2459.
Roizman, B., Pellett, P.E., 2001. Field’s Virology, in: Knipe, D.M., How-
ley, P.M. (Eds.), fourth ed., Lippincott Williams & Wilkins, Philadel-
phia, pp. 2381–2397.
Skepper, J., Whiteley, A., Browne, H., Minson, A., 2001. Herpes simplex
virus nucleocapsids mature to progeny virions by an envelopment-
deenvelopment-reenvelopment pathway. J. Virol. 75, 5697–5702.
Smibert, C.A., Popova, B., Xiao, P., Capone, J.P., Smiley, J.R., 1994.
Herpes simplex virus VP16 forms a complex with the virion host
shutoff protein vhs. J. Virol. 68, 2339–2346.
Spear, P.G., 1994. Viral Fusion Mechanisms, in: Bentz, J. (Ed.), CRC
Press, Boca Raton, FL, pp. 201–232.
Whiteley, A., Bruun, B., Minson, T., Browne, H., 1999. Effects of targeting
herpes simplex virus type 1 gD to the endoplasmic reticulum and
trans-Golgi network. J. Virol. 73, 9515–9520.
Wilson, D.W., Davis-Poynter, N., Minson, A.C., 1994. Mutations in the
cytoplasmic tail of herpes simplex virus glycoprotein H suppress cell
fusion by a syncytial strain. J. Virol. 68, 6985–6993.
Wilson, D.W., Lewis, M.J., Pelham, H.R., 1993. pH-dependent binding of
KDEL to its receptor in vitro. J. Biol. Chem. 268, 7465–7468.
Zhu, Q., Courtney, R.J., 1994. Chemical cross-linking of virion envelope
and tegument proteins of herpes simplex virus type 1. Virology 204,
590–599.
12 S.T. Gross et al. / Virology 317 (2003) 1–12
